Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease

Clinical and Translational Science(2025)10.1111/cts.70086Source: DataRank Database

Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease is a research paper published in Clinical and Translational Science (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 5.91)OA: goldTopics (31)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kei Irie ORCID,Tomoyuki Mizuno ORCID,Jack Reifenberg ORCID,Nieko Punt ORCID,Alexander A. Vinks ORCID

Live enrichment

PubMed:39985779 OpenAlex:https://openalex.org/W4407852860

FWCI

5.91

Citation Percentile

1.0%

Citation Trend

2025

goldLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70086

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70086

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70086

journalhttps://doi.org/10.1111/cts.70086

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39985779

Fields of Study

Inflammatory Bowel DiseaseMicroscopic ColitisHelicobacter pylori-related gastroenterology studies

MeSH Terms

InfliximabAdolescentBlood SedimentationChildCrohn DiseaseDose-Response Relationship, DrugFemaleGastrointestinal AgentsHumansMaleModels, BiologicalSerum AlbuminBiomarkersTreatment OutcomeDrug MonitoringReceptors, IgGPrecision Medicine

Keywords

InfliximabMedicineCovariatePharmacokineticsDosingTherapeutic drug monitoringInternal medicineErythrocyte sedimentation rateDiseasePharmacologyStatistics

Sustainable Development Goals

SDG 0: Reduced inequalitiesSDG 0: Peace, Justice and strong institutions